🇪🇺 Refacto Af in European Union

EMA authorised Refacto Af on 13 April 1999

Marketing authorisation

EMA — authorised 13 April 1999

  • Marketing authorisation holder: Pfizer Ltd
  • Status: approved

Refacto Af in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Refacto Af approved in European Union?

Yes. EMA authorised it on 13 April 1999.

Who is the marketing authorisation holder for Refacto Af in European Union?

Pfizer Ltd holds the EU marketing authorisation.